These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 30375086)

  • 1. Adverse reaction reports of neuroleptic malignant syndrome induced by atypical antipsychotic agents in the Japanese Adverse Drug Event Report (JADER) database.
    Anzai T; Takahashi K; Watanabe M
    Psychiatry Clin Neurosci; 2019 Jan; 73(1):27-33. PubMed ID: 30375086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic malignant syndrome associated with atypical antipsychotic drugs.
    Trollor JN; Chen X; Sachdev PS
    CNS Drugs; 2009; 23(6):477-92. PubMed ID: 19480467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome and atypical antipsychotic drugs.
    Ananth J; Parameswaran S; Gunatilake S; Burgoyne K; Sidhom T
    J Clin Psychiatry; 2004 Apr; 65(4):464-70. PubMed ID: 15119907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome during a change from haloperidol to risperidone.
    Reeves RR; Mack JE; Torres RA
    Ann Pharmacother; 2001 Jun; 35(6):698-701. PubMed ID: 11408988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome induced by atypical antipsychotics.
    Farver DK
    Expert Opin Drug Saf; 2003 Jan; 2(1):21-35. PubMed ID: 12904122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality of neuroleptic malignant syndrome induced by typical and atypical antipsychotic drugs: a propensity-matched analysis from the Japanese Diagnosis Procedure Combination database.
    Nakamura M; Yasunaga H; Miyata H; Shimada T; Horiguchi H; Matsuda S
    J Clin Psychiatry; 2012 Apr; 73(4):427-30. PubMed ID: 22154901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone-induced neuroleptic malignant syndrome.
    Sharma R; Trappler B; Ng YK; Leeman CP
    Ann Pharmacother; 1996; 30(7-8):775-8. PubMed ID: 8826559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome associated with long-acting injectable versus oral second-generation antipsychotics: Analyses based on a spontaneous reporting system database in Japan.
    Misawa F; Okumura Y; Takeuchi Y; Fujii Y; Takeuchi H
    Schizophr Res; 2021 May; 231():42-46. PubMed ID: 33752105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
    Khouri C; Planès S; Logerot S; Villier C; Mallaret M
    Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone-induced neuroleptic malignant syndrome: a case report and review.
    Meterissian GB
    Can J Psychiatry; 1996 Feb; 41(1):52-4. PubMed ID: 8919425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of neuroleptic malignant syndrome induced by first- and second-generation antipsychotics.
    Trollor JN; Chen X; Chitty K; Sachdev PS
    Br J Psychiatry; 2012 Jul; 201(1):52-6. PubMed ID: 22626633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of antipsychotics and other drugs on the development and progression of neuroleptic malignant syndrome.
    Kyotani Y; Zhao J; Nakahira K; Yoshizumi M
    Sci Rep; 2023 Oct; 13(1):18459. PubMed ID: 37891209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic malignant syndrome in traumatic brain injury patients treated with haloperidol.
    Bellamy CJ; Kane-Gill SL; Falcione BA; Seybert AL
    J Trauma; 2009 Mar; 66(3):954-8. PubMed ID: 19276778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Expression Profile of Extrapyramidal Symptoms Due to Antipsychotics by Data Mining of Japanese Adverse Drug Event Report (JADER) Database.
    Kose E; Uno K; Hayashi H
    Yakugaku Zasshi; 2017; 137(1):111-120. PubMed ID: 28049887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool.
    Sokoro AA; Zivot J; Ariano RE
    Ann Pharmacother; 2011 Sep; 45(9):e50. PubMed ID: 21878660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome complicating antipsychotic treatment of delirium or agitation in medical and surgical patients: case reports and a review of the literature.
    Seitz DP; Gill SS
    Psychosomatics; 2009; 50(1):8-15. PubMed ID: 19213967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Antipsychotic-Induced Neuroleptic Malignant Syndrome Using a Self-Organizing Map.
    Miyasaka K; Hirofuji S; Maezawa M; Nakao S; Yamashita M; Ichihara N; Nokura Y; Tamaki H; Iguchi K; Nakamura M
    Cureus; 2024 Aug; 16(8):e68260. PubMed ID: 39350836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What clinical analysis of antipsychotic-induced catatonia and neuroleptic malignant syndrome tells us about the links between these two syndromes: A systematic review.
    Virolle J; Redon M; Montastruc F; Taïb S; Revet A; Zivkovic V; Da Costa J; Very E
    Schizophr Res; 2023 Dec; 262():184-200. PubMed ID: 37599139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic Malignant Syndrome.
    Pileggi DJ; Cook AM
    Ann Pharmacother; 2016 Nov; 50(11):973-981. PubMed ID: 27423483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.